Minerva Neurosciences, Inc (NASDAQ:NERV – Free Report) – Stock analysts at HC Wainwright raised their FY2025 earnings per share estimates for Minerva Neurosciences in a research note issued on Thursday, November 6th. HC Wainwright analyst D. Tsao now anticipates that the biopharmaceutical company will post earnings per share of ($1.40) for the year, up from [...]
Read Original Source© 2026 News4Crypto.eu. All rights reserved.